Physician

Jigar Kanubhai Shah, MD

According to 2025 Medicare claims, Jigar Shah, MD (NPI: 1013936079) practices hematology/oncology in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Montgomery, TN. This provider's primary affiliated billing organization is CANCER CARE, PLC (NPI: 1265628226; TIN: 26-0707611) and primary practice location at 37043-5653.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 390 traditional Medicare patients, billed 58,956 HCPCS/CPT codes, and received $1,121,269 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,255 prescription claims across 219 beneficiaries totaling $1,640,514 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 12 claims. Open Payments data shows 3 records totaling $621. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,851,230 to $1,121,269. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $531,364 to $1,640,514. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	493	390,405	$1,851,230
2016	480	250,908	$1,773,514
2017	485	203,838	$1,712,034
2018	491	117,394	$2,244,023
2019	493	116,421	$1,842,896
2020	476	118,256	$1,967,614
2021	446	96,440	$1,471,420
2022	425	73,326	$1,771,566
2023	407	89,174	$1,336,534
2024	390	58,956	$1,121,269

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	107	571	$531,364
2016	148	850	$1,020,347
2017	174	1,116	$1,333,442
2018	169	958	$1,324,846
2019	187	1,106	$1,718,315
2020	197	1,048	$2,172,032
2021	189	1,118	$1,806,646
2022	195	1,067	$2,641,981
2023	201	1,052	$1,900,290
2024	219	1,255	$1,640,514

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	41	$5,816
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$109
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	317	838	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	202	848	$67
99491	Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month	142	320	$65
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	180	482	$48
96372	Injection of drug or substance under skin or into muscle	148	1,157	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	151	7,668	$149,068
Xarelto	Rivaroxaban	160	7,440	$131,615
Brukinsa	Zanubrutinib	11	330	$86,179
Imatinib Mesylate	Imatinib Mesylate	18	632	$30,352
Retacrit	Epoetin Alfa-Epbx	12	406	$21,364

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$621	US Oncology Corporate, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jigar Kanubhai Shah, MD?

Tedicare shows public-source Medicare data for Jigar Kanubhai Shah, MD (NPI 1013936079), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jigar Kanubhai Shah, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jigar Kanubhai Shah, MD?

Jigar Kanubhai Shah, MD is linked to CANCER CARE, PLC (billing NPI 1265628226) in the available physician profile data.

Does Jigar Kanubhai Shah, MD have Open Payments data?

Jigar Kanubhai Shah, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.